Key result
Long cardiac troponin T assay outperforms standard hs-cTnT for diagnosing myocardial infarction.
Why the study?
Data on the performance of long cardiac troponin T assays in myocardial infarction diagnosis across the full spectrum of kidney function were limited.
Does a long cTnT assay improve the diagnostic accuracy of myocardial infarction compared to standard hs-cTnT in emergency department patients with elevated hs-cTnT?
Observational (n=1,811)
Does a long cTnT assay improve the diagnostic accuracy of myocardial infarction compared to standard hs-cTnT in emergency department patients with elevated hs-cTnT?
p-value: p=<0.001
Unlike standard hs-cTnT, long cTnT is unaffected by kidney function and provides superior diagnostic accuracy for myocardial infarction, particularly in patients with reduced eGFR.
Long cTnT may aid MI diagnosis across kidney function; leaves open whether it improves outcomes or should replace hs-cTnT.
BACKGROUND AND HYPOTHESIS: A recently developed cardiac troponin T (cTnT) assay measuring intact or mildly fragmented cTnT (long cTnT) has shown promise in improving the accuracy of myocardial infarction (MI) detection compared to the commercial high sensitivity cTnT (hs-cTnT) assay. However, data on patients with kidney dysfunction are limited. We compared the performance of long and hs-cTnT in MI diagnostics across the full spectrum of kidney function. METHODS: In this prospective study, consecutive patients presenting at the emergency department with an elevated (≥14 ng/L) hs-cTnT were recruited. Long and hs-cTnT were measured on admission and kidney function was determined with plasma creatinine (Crea), cystatin C (CysC) and estimated glomerular filtration rate (eGFR) using contemporary equations with Crea, CysC or both (Crea-CysC) together. The association of eGFR with hs-cTnT and long cTnT concentrations and the discriminative ability of hs-cTnT and long cTnT for type 1 MI and any MI were evaluated. RESULTS: In total, 1811 patients were included, 205 (11.3%) had a MI and 204 (11.3%) had a history of chronic kidney disease. The overall median (interquartile range) Crea-eGFR, CysC-eGFR and Crea-CysC-eGFR were 71 (51-87), 52 (36-69) and 63 (44-79) ml/min/1.73m2. In patients without MI, long cTnT showed no consistent association with kidney function (β=0.0008, P = 0.050; β=0.0005, P = 0.222; β=0.0006, P = 0.182 for Crea-eGFR, CysC-eGFR and Crea-CysC-eGFR, respectively), whereas hs-cTnT was inversely associated with kidney function (β=-0.0032, -0.0035 and - 0.0035; all P < 0.001). Long cTnT demonstrated superior diagnostic performance compared with hs-cTnT for the detection of MI (P < 0.001), with the advantage becoming progressively more pronounced with lower eGFR irrespective of equation used. CONCLUSIONS: In contrast to hs-cTnT, long cTnT is unaffected by kidney function and outperforms hs-cTnT in the detection of MI, with the greatest diagnostic advantage observed in patients with lower eGFR.
No takes yet. Share an insight, caveat, or question.
Hellman et al. (2026) conducted an observational in Suspected myocardial infarction with elevated hs-cTnT (n=1,811). Long cardiac troponin T (cTnT) assay vs. High sensitivity cardiac troponin T (hs-cTnT) assay was evaluated on Detection of type 1 myocardial infarction and any myocardial infarction (p=<0.001). The long cardiac troponin T assay demonstrated superior diagnostic performance compared to the hs-cTnT assay for the detection of myocardial infarction (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: